Skip to main content
Weiqiang Zhao, MD, Pathology, Columbus, OH, Ohio State University Wexner Medical Center

WeiqiangZhaoMDPhD, FCAP

Pathology • Columbus, OH

Hematopathology, Molecular Genetics, Anatomic Pathology, Clinical Pathology

Professor of Pathology, Ohio State University College of Medicine Columbus, OH Medical Director, James Molecular Laboratory at Polaris Medical Director, Cytogenetics Lab, James Cancer Center/Hospital

Join to view full profile

Dr. Zhao is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Zhao's full profile

Already have an account?

Summary

  • Dr. Weiqiang Zhao is a pathologist in Columbus, OH affiliated with multiple hospitals in the area, including Ohio State University Wexner Medical Center and James Cancer Hospital and Solove Research Institute. He received his medical degree from Hunan Medical University and has been in practice 35 years. He also speaks multiple languages, including Chinese (Mandarin). He specializes in hematopathology, molecular genetics, anatomic pathology, and clinical pathology and is experienced in the diagnosis of acute myeloid leukemia, lymphoma, non-small cell lung cancer, acute lymphoblastic leukemia, and myeloproliferative neoplasms.

Education & Training

  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Molecular Genetic Pathology, 2006 - 2007
  • Tulane University
    Tulane UniversityFellowship, Hematopathology, 2005 - 2006
  • Tulane University
    Tulane UniversityResidency, Pathology-Anatomic and Clinical, 2003 - 2005
  • Hunan Medical University
    Hunan Medical UniversityClass of 1982

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2007 - 2025
  • LA State Medical License
    LA State Medical License 2004 - 2007
  • American Board of Pathology Anatomic Pathology & Clinical Pathology
  • American Board of Pathology Pathology - Molecular Genetic
  • American Board of Pathology Hematopathology

Publications & Presentations

PubMed

Journal Articles

  • Givinostat, A Type II Histone Deacetylase Inhibitor, Induces Potent Caspase-Dependent Apoptosis in Human Lymphoblastic Leukemia.  
    Li Ying, K Zhao, C Yao, S Kahwash, Y Tang, G Zhang, K Patterson, Qi-En Wang, W Zhao, Genes & Cancer, 9/24/2016

Abstracts/Posters

  • Newly Diagnosed AML Patient Samples Demonstrate High Degree of Concordance in Identification of Pathogenic Mutations By Next Generation Sequencing (NGS) Performed at E...
    Weiqiang Zhao, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Mutations in the Ras Pathway in Pre-Treatment Chronic Lymphocytic Leukemia Are Associated with VH1-69: Linking B-Cell Receptor Stereotypy to Downstream Signaling Events 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Multi-Gene Testing Could Detect More Hereditary Cancer Syndromes
    Multi-Gene Testing Could Detect More Hereditary Cancer SyndromesMay 10th, 2021

Committees

  • Committee Scientific Expert, Committee to Review the Styrene Assessment in the National Toxicology Program 12th Report on Carcinogens, National Academies, Board of Environmental Studies and Toxicology, Washington DC. 2013 - 2014

Professional Memberships

Other Languages

  • Chinese (Mandarin)

Hospital Affiliations

External Links

Dr. Weiqiang Zhao, Dr. Weiqiang Zhao, MD, Dr. W Zhao